Anti-CD22 immunoconjugate inotuzumab ozogamicin plus rituximab followed by stem cell transplantation in relapsed/refractory DLBCL patients: Safety and efficacy Meeting Abstract
| Authors: | Wagner-Johnston, N.; Goy, A.; Rodriguez, M. A.; Ehmann, C.; Hamlin, P.; Radford, J.; Thieblemont, C.; Suh, C.; Sweetenham, J.; Jiang, Y.; Sullivan, S. T.; Vandendries, E. R.; Gisselbrecht, C. |
| Abstract Title: | Anti-CD22 immunoconjugate inotuzumab ozogamicin plus rituximab followed by stem cell transplantation in relapsed/refractory DLBCL patients: Safety and efficacy |
| Meeting Title: | 53rd Annual Meeting and Exposition of the American Society of Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis |
| Journal Title: | Blood |
| Volume: | 118 |
| Issue: | 21 |
| Meeting Dates: | 2011 Dec 10-13 |
| Meeting Location: | San Diego, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2011-11-01 |
| Start Page: | 1169 |
| End Page: | 1170 |
| Language: | English |
| ACCESSION: | WOS:000299597104069 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood.V116.21.2883.2883 |
| Notes: | --- - Meeting Abstract: 2718 - 53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis - DEC 10-13, 2011 - San Diego, CA - "Source: Wos" |
